Synthetic lethal interaction between ARID1A mutation and BET bromodomain inhibition in ovarian clear cell carcinoma

被引：2
|
作者：
Berns, Katrien
Caumanns, Joseph J.
Hijmans, E. Marielle
Gennissen, Annemiek
Evers, Bastiaan
Wisman, Bea A.
Meersema, Gert Jan
Lieftink, Cor
Beijersbergen, Roderick L.
Itamochi, Hiroaki
van der Zee, Ate G.
de Jong, Steven
Bernards, Rene
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-3380
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3380
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Suppression of ARID1A associated with decreased CD8 T cells improves cell survival of ovarian clear cell carcinoma
    Jung, Un Suk
    Min, Kyueng-Whan
    Kim, Dong-Hoon
    Kwon, Mi Jung
    Park, HoHyun
    Jang, Hyung Seok
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (01) : 1 - 13
  • [42] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    MODERN PATHOLOGY, 2013, 26 : 289A - 290A
  • [43] Establishment and characterization of a novel ovarian clear cell carcinoma cell line, TU-OC-2, with loss of ARID1A expression
    Seiya Sato
    Hiroaki Itamochi
    Nao Oumi
    Youhei Chiba
    Tetsuro Oishi
    Muneaki Shimada
    Shinya Sato
    Jun Chikumi
    Michiko Nonaka
    Akiko Kudoh
    Hiroaki Komatsu
    Tasuku Harada
    Toru Sugiyama
    Human Cell, 2016, 29 : 181 - 187
  • [44] Synthetic lethal interaction between SETD2 loss and inhibition of PI3Kβ in clear cell renal cell carcinoma (ccRCC)
    Terzo, Esteban
    Chiang, Yun C.
    Chytil, Anna
    Jansen, Valerie M.
    Rathmell, Kimryn
    CANCER RESEARCH, 2018, 78 (13)
  • [45] BAF250a (ARID1A) Expression in Ovarian Clear Cell Adenocarcinoma with an Adenofibromatous Component
    Nishikimi, K.
    Kiyokawa, T.
    Tate, S.
    Iwamoto, M.
    Kisimoto, T.
    Fugo, K.
    Shozu, M.
    LABORATORY INVESTIGATION, 2013, 93 : 289A - 290A
  • [46] Loss-Of-Function Mutation Of ARID1A Tumor Suppressor Gene In A Glycogen-Rich Clear Cell Mammary Carcinoma
    Verduzco, C. A. De la Sancha
    Popnikolov, N.
    Ruiz-Cordero, R.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S146 - S146
  • [47] Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
    Ge, Huijuan
    Xiao, Yaoxin
    Qin, Guangqi
    Gu, Yanzi
    Cai, Xu
    Jiang, Wenhua
    Tu, Xiaoyu
    Yang, Wentao
    Bi, Rui
    DIAGNOSTIC PATHOLOGY, 2021, 16 (01)
  • [48] Mismatch repair deficiency is associated with specific morphologic features and frequent loss of ARID1A expression in ovarian clear cell carcinoma
    Huijuan Ge
    Yaoxin Xiao
    Guangqi Qin
    Yanzi Gu
    Xu Cai
    Wenhua Jiang
    Xiaoyu Tu
    Wentao Yang
    Rui Bi
    Diagnostic Pathology, 16
  • [49] The Chromatin Remodeling Gene, ARID1A, Is a New Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Wala, S. J.
    Lichner, Z.
    Scorilas, A.
    White, N. M. A.
    Girgis, A. H.
    Rotstein, L.
    Wiegand, K. C.
    Latif, A.
    Chow, C.
    Huntsman, D.
    Yousef, G. M.
    LABORATORY INVESTIGATION, 2013, 93 : 255A - 255A
  • [50] The Chromatin Remodeling Gene ARID1A Is a New Prognostic Marker in Clear Cell Renal Cell Carcinoma
    Lichner, Zsuzsanna
    Scorilas, Andreas
    White, Nicole M. A.
    Girgis, Andrew H.
    Rotstein, Lora
    Wiegand, Kimberly C.
    Latif, Ashraf
    Chow, Christina
    Huntsman, David
    Yousef, George M.
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (04): : 1163 - 1170
12345